World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
97
Citations
35969
World Ranking
9255
National Ranking
358

Dik J. Kwekkeboom publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Dik J. Kwekkeboom sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 239 publications — 7th percentile

7% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Dik J. Kwekkeboom D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Dik J. Kwekkeboom sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 97 D-Index — 55th percentile

55% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Dik J. Kwekkeboom was affiliated with Erasmus University Rotterdam in the Netherlands. Their academic work primarily focused on the field of Medicine, contributing to subfields such as Epidemiology, Oncology, Radiology, Nuclear Medicine and Imaging, and Neurology.

The research topics covered by Kwekkeboom included:

  • Neuroendocrine Tumor Research Advances
  • Lung Cancer Research Studies
  • Radiopharmaceutical Chemistry and Applications
  • Neuroblastoma Research and Treatments

Kwekkeboom authored at least one recent paper titled PRRT neuroendocrine tumor response assessment using blood transcript analysis: The NETest, published in 2020 in the Journal of Clinical Oncology.

Frequent collaborators included the following coauthors:

  • Lisa Bodei
  • Mark A. Kidd
  • Aviral Singh
  • Wouter A. van der Zwan
  • Stefano Severi

Their publications appeared primarily in the Journal of Clinical Oncology.

Best Publications

  • Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors

    Jonathan Strosberg;G. El-Haddad;Edward Wolin;A. Hendifar

  • Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients

    E. P. Krenning;D. J. Kwekkeboom;W. H. Bakker;W. A. P. Breeman

  • Treatment With the Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate: Toxicity, Efficacy, and Survival

    Dik J. Kwekkeboom;Wouter W. de Herder;Boen L. Kam;Casper H. van Eijck

  • ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors.

    M. Falconi;B. Eriksson;G. Kaltsas;D.K. Bartsch

  • Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate in Patients With Endocrine Gastroenteropancreatic Tumors

    Dik J. Kwekkeboom;Jaap J. Teunissen;Willem H. Bakker;Peter P. Kooij

  • The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours

    John J. Zaknun;L. Bodei;J. Mueller-Brand;M. E. Pavel

  • Neuroendocrine gastro-entero-pancreatic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    K. Öberg;U. Knigge;D. Kwekkeboom;A. Perren

  • [177Lu-DOTA0, Tyr3]octreotate : comparison with [111In-DTPA0]octreotide in patients

    Dik J. Kwekkeboom;Willem H. Bakker;Peter P. M. Kooij;Mark W. Konijnenberg

  • Long-Term Efficacy, Survival, and Safety of [177Lu-DOTA0,Tyr3]octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumors

    Tessa Brabander;Wouter A. van der Zwan;Jaap J.M. Teunissen;Boen L.R. Kam

  • Recommendations for management of patients with neuroendocrine liver metastases

    Andrea Frilling;Irvin M. Modlin;Mark Kidd;Christopher Russell

  • Overview of Results of Peptide Receptor Radionuclide Therapy with 3 Radiolabeled Somatostatin Analogs

    Dik J Kwekkeboom;Jan Mueller-Brand;Giovanni Paganelli;Lowell B Anthony

  • Somatostatin receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors

    Dik J Kwekkeboom;Boen L Kam;Martijn van Essen;Jaap J M Teunissen

  • Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones.

    F. R. E. Nobels;D. J. Kwekkeboom;W. Coopmans;C. H. H. Schoenmakers

  • Treatment of patients with gastro-entero-pancreatic (GEP) tumours with the novel radiolabelled somatostatin analogue [177Lu-DOTA0, Tyr3]octreotate

    D. J. Kwekkeboom;W. H. Bakker;B. L. Kam;J. J. M. Teunissen

  • Somatostatin receptor-targeted radionuclide therapy of tumors: Preclinical and clinical findings

    Marion de Jong;Roelf Valkema;Francois Jamar;Larry K. Kvols

  • Peptide Receptor Imaging and Therapy

    Dik Kwekkeboom;Eric P. Krenning;Marion de Jong

  • Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors

    Lisa Bodei;Mark Kidd;Giovanni Paganelli;Chiara M. Grana

  • ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: peptide receptor radionuclide therapy with radiolabeled somatostatin analogs.

    Rodney J Hicks;Dik J Kwekkeboom;Eric Krenning;Lisa Bodei

  • Long-term follow-up of renal function after peptide receptor radiation therapy with (90)Y-DOTA(0),Tyr(3)-octreotide and (177)Lu-DOTA(0), Tyr(3)-octreotate.

    Roelf Valkema;Stanislas A Pauwels;Larry K Kvols;Dik J Kwekkeboom

  • Survival and response after peptide receptor radionuclide therapy with [90Y -DOTA0,Tyr3]octreotide in patients with advanced gastroenteropancreatic neuroendocrine tumors

    Roelf Valkema;Stanislas Stanislas Pauwels;Larry Kvols;Raffaella Barone

Frequent Co-Authors

Eric P. Krenning
Eric P. Krenning Erasmus University Rotterdam
Wouter W. de Herder
Wouter W. de Herder Erasmus University Rotterdam
Marion de Jong
Marion de Jong Erasmus University Rotterdam
Kjell Öberg
Kjell Öberg Uppsala University
Irvin M. Modlin
Irvin M. Modlin Yale University
Philippe Ruszniewski
Philippe Ruszniewski Université Paris Cité
Giovanni Paganelli
Giovanni Paganelli Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori
Larry K. Kvols
Larry K. Kvols University of South Florida
Jean Claude Reubi
Jean Claude Reubi University of Bern
Mark Kidd
Mark Kidd Wren Laboratories

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in alternative or complementary routes to a medical career in the USA, there are several flexible online programs to consider. Accelerated learning options are now available, making it possible to enter healthcare fields faster than ever before.

One popular choice is the lpn accelerated program, which enables students to become Licensed Practical Nurses quickly through an intensive online format. For those leaning toward mental health, the fast track mental health nursing pathway offers an expedited route to advanced credentials in psychiatric nursing.

If you're more interested in the administrative side of healthcare, consider pursuing a health administration degree. These programs provide key leadership and management skills for running medical facilities. For graduate-level advancement, look into cheap mha programs that offer affordability without sacrificing quality.

Whether your interests are clinical or administrative, these online degree pathways can help you enter or advance within the healthcare sector, offering versatility and accessibility for a wide range of learners.

Best Scientists Citing Dik J. Kwekkeboom

Recently Published Articles